Michael Ehlers, MD, PhD, stepped down as Biogen’s executive vice president of R&D to pursue another job opportunity. He will leave the company Oct. 11.
Dr. Ehlers will be replaced by Biogen’s current CMO Alfred Sandrock Jr., MD, PhD. Dr. Sandrock will continue to serve as CMO in addition to his new executive role.
Alphonse Galdes, PhD, was named the executive vice president of pharmaceutical operations and technology. Dr. Galdes has been with Biogen since 1995, serving in several senior leadership positions, including most recently as senior vice president, asset development and portfolio management.
Read the full news release here.
More articles on pharmacy:
Following CVS, Walgreens and Rite Aid pull Zantac from shelves
Telemedicine startup to open first brick-and-mortar pharmacy
Top 10 pharmacy stories in September
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.